<?xml version="1.0" encoding="UTF-8"?>
<p id="Par16">There are no medications specifically licensed by the US Food and Drug Administration (FDA) for the treatment of COVID-19 patients. In several hundred clinical trials that are ongoing across the globe, many drugs approved for other indications as well as other investigational drugs are being studied. Two of the approved drugs (chloroquine and hydroxychloroquine) and one of the commonly used research agents (remdesivir) are in the limelight for the whole world on that basis (Centers for Disease Control and Prevention, CDC 
 <xref ref-type="bibr" rid="CR4">2020</xref>)
</p>
